Skip to main content
Caplight Logo









Beacon Biosignals

Beacon Biosignals

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://beacon.bio/

Last Round

Series C

Jun 9, 2026

Est. Valuation

$286.85M

Total Funding Raised

$452M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Beacon Biosignals is a healthcare technology company that provides an artificial intelligence-driven EEG analysis and diagnosis platform to accelerate drug development and improve brain health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

electroencephalogramEEGbrain biomarkerneurotechnologyclinical trial softwaredigital biomarkerwearable EEGsleep AImedical AIpatient stratificationneurodiagnosticbrain health analyticsremote sleep monitoringhealthtechbiotech analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beacon Biosignals Comparables

Compare Beacon Biosignals with similar companies based on industry and business-model similarity.

Beacon Biosignals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cumulus Neuroscience
77%
Zeto, Inc.
77%
Empatica
76%

Beacon Biosignals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 9, 2026
Series BApr 6, 2026
Series BNov 13, 2025
Series ANov 8, 2021
SeedMay 30, 2019
Seed
May 1, 2019

Key People

Founding team and executive leadership

Jacob Donoghue

Co-Founder And CEO

Founding Team

Jarrett Revels

Chief Technology Officer

Executive Team

Beacon Biosignals Investors

Notable investors and investment history

Beacon Biosignals investors
InvestorRounds
S32Series B
Kicker VenturesSeries B
GVSeries B
JSL Health CapitalSeries B
Nexus NeuroTech VenturesSeries B
InnovivaSeries B
Catalio Capital ManagementSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Grew 38% QoQ, from 121 to 167 employees.

  • Jun 9, 2026

    $225M round led by General Catalyst and HarbourVest Partners.

Beacon Biosignals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beacon Biosignals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beacon Biosignals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range171
Year Founded2019
Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?